Autopsy report · NCT02790996

Neonatal Vancomycin Trial

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Planned interim analysis yielded different event rate affecting sample size and ability to recruit sufficient numbers within remaining trial time frame”

The sponsor’s own words in the registry.

Life of this trial

Registered 11 months before it started.
Ran for about 3 years 1 month before it stopped.
242 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: PENTA Foundation
Sponsor type: University, hospital or other
Conditions: Late Onset Neonatal Sepsis
Interventions: Vancomycin
Participants: 242
Sites: 18
Countries: Estonia, Greece, Italy, Spain, United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.